Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FlexShopper Expands Lease-to-Own Solutions at Jiffy Lube and Meineke Car Care Centers
-
Nayax Deploys OTI PetroSmart's Fuel Management System in Tesco's UK Delivery Truck Fleet
-
Revival Gold 2024 Year in Review
-
TMC Applauds U.S. Congressional Mandate for 2025 Defense Department Feasibility Study on Nodule Refining
-
VDIAGTOOL launches VDIAGTOOL VD70S, the First Under-$400 Diagnostic tool with WiFi & USB Connectivity
-
AGF Investments Announces Final Distributions for AGF Investments ETFs for 2024
-
VDIAGTOOL launches VDIAGTOOL VD70S, the First Under-$400 Diagnostic tool with WiFi & USB Connectivity
-
Syntiant Completes Acquisition of Knowles’ Consumer MEMS Microphone Division
-
Tesonet's CIO Eglė Eidimtaitė joins PayPal's Customer Advisory Board
-
Tesonet's CIO Eglė Eidimtaitė joins PayPal's Customer Advisory Board
-
Gilat Receives Over $18 Million in Orders for its In-Flight Connectivity Solutions
-
Kintavar to Sell the Fer à Cheval Outfitter
-
Altus Group Provides Update on Sale of its Property Tax Business to Ryan, LLC
-
Harfang Completes Flow-Through Financing
-
Aya Gold & Silver Declares Commercial Production at New Zgounder Silver Mine Processing Plant
-
Electra Confirms Effective Date for Reverse Share Split
-
Marimaca Makes Pampa Medina Norte Discovery – Intersects 18m at 5.1% CuT within 102m at 1.2% CuT, both within a broad zone of 400m at 0.5% CuT
-
O2Gold Provides Update On Quebec Aur Transaction
-
American Lithium Announces Trading On the OTCQX Market
-
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
-
Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson
-
Brazil Potash (NYSE American: GRO) Converts Its Water Extraction Installation Licenses Into Full Operational Permits at Its Autazes Potash Project Located in the Amazonas State of Brazil
-
Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
-
Amplify ETFs Declares December Income Distributions for its Income ETFs
-
Incora Announces Confirmation of Plan of Reorganization
-
OTC Markets Group Welcomes American Lithium Corp. to OTCQX
-
OTC Markets Group Welcomes Acuren Corporation to OTCQX
-
Orion and Marinus terminate agreement for ganaxolone in Europe
-
Invesco Ltd: Form 8.3 - International Paper Co; Public dealing disclosure
-
Vanguard Announces Final Cash Distributions for the Vanguard ETFs
-
Vanguard Investments Canada Announces Final 2024 Annual Capital Gains Distributions for the Vanguard ETFs®
-
Bitget Introduces PoolX Winter Carnival with 15,440 BGB in Rewards
-
Bitget Completes First-Ever Burn of 800 Million BGB Tokens, Reducing Supply by 40%
-
Hola Prime Establishes Industry's First Dedicated Risk Compliance Team
-
Hola Prime Establishes Industry's First Dedicated Risk Compliance Team
-
Jeffs’ Brands Announces Drone Safety Systems Now Available on Amazon US
-
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Equinor ASA: Share buy-back
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Form 8.3 - [ECKOH PLC - 27 12 2024] - (CGWL)
-
Bitget Wallet Hits 60M Users with 300% Growth in 2024
-
Tower Semiconductor to Attend the 27th Annual Needham Growth Conference in New York
-
Ragnarok: Rebirth Received an ISBN Code by Chinese Government
-
European Wax Center, Inc. Announces Participation in the 2025 ICR Conference
-
Transactions in connection with share buyback programme
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
Share Buyback Transaction Details December 19 – December 27, 2024
-
Subsea7 awarded contract offshore Türkiye
-
Form 8.5 (EPT/RI) - Warpaint London Plc
